Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-17-022532

Options or other derivatives

  • Chief Scientific Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Erlander Mark · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-04-07 Grant or award : show line 1 in the form Restricted Stock Units +90,000 195,001 D
Loading xslF345X03/a4.xml…